Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-04-07 2020-04-07
Drug Identification Number 00155357 00155357
Brand name ADRENALIN CHLORIDE SOL 1:1000 AMP ADRENALIN CHLORIDE SOL 1:1000 AMP
Common or Proper name ADRENALIN INJ 1ML ADRENALIN INJ 1ML
Company Name ERFA CANADA 2012 INC ERFA CANADA 2012 INC
Ingredients EPINEPHRINE EPINEPHRINE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10X1ML 10X1ML
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-03-20 2020-03-20
Actual start date 2020-03-20 2020-03-20
Estimated end date 2020-04-06 2020-04-06
Actual end date 2020-04-06 2020-04-06
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments